Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
As of today, Collegium Pharmaceutical(COLL) shares are valued at $43.95. The company's market cap stands at 1.39B, with a P/E ratio of 27.68.
As of 2025-11-21, Collegium Pharmaceutical(COLL) stock has fluctuated between $43.78 and $45.33. The current price stands at $43.95, placing the stock +0.4% above today's low and -3.0% off the high.
The Collegium Pharmaceutical(COLL)'s current trading volume is 445.42K, compared to an average daily volume of 600.83K.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $48.18 and a 52-week low of $23.23.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $48.18 and a 52-week low of $23.23.
COLL News
Building the scenario for the Zacks Bull of the Day, broader valuation concerns have stemmed from the tech sector, with the market also on edge about delayed in...
New insider activity at Collegium Pharmaceutical ( (COLL) ) has taken place on November 14, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst...
Collegium Pharmaceutical, Inc. reported that for the third quarter ended September 30, 2025, net income rose to US$31.51 million from US$9.34 million a year ear...
